To include your compound in the COVID-19 Resource Center, submit it here.

Analyst picks & changes

Analyst picks & changes

Company Bank Analyst Coverage Opinion Wk chg 7/29 cls
Biogen Idec Inc. (NASDAQ:BIIB) Baird Christopher Raymond Price target Neutral -4% $101.87
Jefferies Thomas Wei Price target Buy
Leerink Joshua Schimmer Price target Market outperform
Raymond raised his target to $100 from $90 after Biogen Idec reported 2Q11 non-GAAP EPS of $1.36, beating his

Read the full 854 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers